Internal Medicine, Rheumatology · Mountain Brk, AL
NPI
1417932849
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
12 Office Park Cir
Mountain Brk, AL, 35223
Phone (205) 933-0320
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.7M
112,906 services
Medicare patients, 2024
379
Average age 74
Drug cost, 2024
$2.1M
5,597 prescriptions
Company payments, 2025
$14K
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Peter A Saway was code J1602 (injection, golimumab, 1 mg, for intravenous use), 20,300 times for 24 patients. In total Peter A Saway billed 112,906 services in 88 codes, and Medicare paid $1.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 20,300 | 24 | $9.12 | $185K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 15,950 | 30 | $33.31 | $531K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 5,380 | 17 | $24.94 | $134K |
| J0897 Injection, denosumab, 1 mg | Office | 4,860 | 62 | $19.91 | $97K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 2,791 | 54 | $0.10 | $277 |
| 99214 Office E&M - Established | Office | 418 | 231 | $85.91 | $36K |
| 96365 Intravenous Infusion, Hydration | Office | 416 | 60 | $43.61 | $18K |
| 99213 Office E&M - Established | Office | 312 | 213 | $59.86 | $19K |
| 86235 Immunoassay | Office | 189 | 20 | $17.57 | $3,321 |
| 96413 Chemotherapy Administration | Office | 184 | 53 | $86.13 | $16K |
| 96415 Chemotherapy Administration | Office | 163 | 23 | $19.18 | $3,127 |
| 96372 Injection Administration | Office | 135 | 80 | $9.47 | $1,278 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 120 | 24 | $4.39 | $526 |
| 85025 Blood Count | Office | 103 | 94 | $7.61 | $784 |
| 77080 Standard X-ray | Office | 77 | 77 | $35.12 | $2,704 |
By year: 2022 $1.9M for 122,628 services; 2023 $1.8M for 125,373 services; 2024 $1.7M for 112,906 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 86235 Immunoassay | 189 | 20 | $17.57 | $3,321 |
| 85025 Blood Count | 103 | 94 | $7.61 | $784 |
| 85652 Clinical Chemistry | 44 | 41 | $2.65 | $117 |
| 86225 Immunoassay | 21 | 20 | $13.47 | $283 |
| 86226 Immunoassay | 21 | 20 | $11.87 | $249 |
| 86038 Immunoassay | 19 | 18 | $11.85 | $225 |
Medicare prescription drug claims, 2024
In 2024, the drug Peter A Saway prescribed most often to Medicare patients was Tramadol Hcl, with 723 prescriptions and refills. In total Peter A Saway wrote 5,597 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tramadol Hcl Generic | 723 | 737 | 125 | $3,921 |
| Hydroxychloroquine Sulfate Generic | 614 | 1,008 | 171 | $30K |
| Prednisone Generic | 475 | 645 | 106 | $3,509 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 327 | 327 | 70 | $4,950 |
| Methotrexate Methotrexate Sodium | 267 | 436 | 65 | $5,295 |
| Gabapentin Generic | 263 | 323 | 51 | $2,592 |
| Meloxicam Generic | 224 | 442 | 74 | $1,072 |
| Duloxetine Hcl Generic | 184 | 296 | 47 | $3,902 |
| Tramadol Hcl-Acetaminophen Tramadol Hcl/Acetaminophen | 163 | 163 | 33 | $3,254 |
| Pregabalin Generic | 154 | 200 | 24 | $8,759 |
| Celecoxib Generic | 135 | 233 | 35 | $6,099 |
| Tizanidine Hcl Generic | 103 | 154 | 32 | $796 |
| Allopurinol Generic | 98 | 222 | 30 | $1,917 |
| Cyclobenzaprine Hcl Generic | 83 | 93 | 24 | $610 |
| Methocarbamol Generic | 80 | 95 | 35 | $754 |
Brand drugs: - claims; generic drugs: 5,152 claims; opioid claims: 1,465.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Peter A Saway $14K ($14K in general payments such as food, travel and fees) from 18 companies. The largest payer was Amgen Inc. with $11K.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 38 | $11K |
| Abbvie Inc. ABBV | 30 | $649 |
| Novartis Pharmaceuticals Corporation NVS | 15 | $380 |
| UCB, Inc. UCB.BR | 17 | $283 |
| GlaxoSmithKline, LLC. GSK | 10 | $238 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $207 |
| Pfizer Inc. PFE | 14 | $204 |
| Mallinckrodt Hospital Products Inc. | 8 | $177 |
| E.R. Squibb & Sons, L.L.C. BMY | 7 | $141 |
| Genzyme Corporation SNY | 3 | $84.39 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.